The Board proposes the rule amendment for Rule 64B16-28.702, F.A.C. to update language regarding sterile compounding for modified class II institution pharmacies. The Board proposes the rule amendment for Rule 64B16-28.750, ....

Document Information

Comments Open:: 1/6/2025
Summary:: For Rule 64B16-28.702, F.A.C. language will be updated regarding sterile compounding for modified class II institution pharmacies. For Rule 64B16-28.750, F.A.C. to language will be updated regarding sterile compounding for Class III pharmacies. For Rule 64B16-28.820, F.A.C. language will be updated regarding special parenteral/enteral compounding. For Rule 64B16-28.860, F.A.C. language will be updated regarding sterile compounding.
Purpose:: The Board proposes the rule amendment for Rule 64B16-28.702, F.A.C. to update language regarding sterile compounding for modified class II institution pharmacies. The Board proposes the rule amendment for Rule 64B16-28.750, F.A.C. to update sterile compounding for Class III pharmacies. The Board proposes the rule amendment for Rule 64B16-28.820, F.A.C. to update language regarding special parenteral/enteral compounding. The Board proposes the rule amendment for Rule 64B16-28.860, F.A.C. to ...
Rulemaking Authority:: 465.005, 465.0155, 465.022 FS.
Law:: 465.0155, 465.022 FS.
Related Rules: (3): 64B16-28.702. Modified Class II Institutional Pharmacies; 64B16-28.820. Sterile Products and Special Parenteral/Enteral Compounding; 64B16-28.860. Special Pharmacy - Parenteral/Enteral Extended Scope Permit